Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 implemented, replacing the previous v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded a Publications entry citing the J Clin Oncol article for NIPINEC and noted that publications are automatically filled from PubMed. Revision history updated to v3.4.3.SummaryDifference0.3%

- Check53 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior Notice about lapse in government funding and Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedA general site notice about potential delays due to a lapse in government funding was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check67 days agoChange DetectedMinor UI/text updates: added a 'Show glossary' option; updated footer labels to 'Last Update Submitted that Met QC Criteria' (from 'Last Update Submitted that met QC Criteria') and to 'No FEAR Act Data' (from 'No FEAR Act data'); updated the revision tag to 'Revision: v3.4.0' (from 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision: v3.3.4 has been added, replacing Revision: v3.3.3. This metadata update does not affect the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.